BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silva-Cayetano A, Foster WS, Innocentin S, Belij-Rammerstorfer S, Spencer AJ, Burton OT, Fra-Bidó S, Le Lee J, Thakur N, Conceicao C, Wright D, Barrett J, Evans-Bailey N, Noble C, Bailey D, Liston A, Gilbert SC, Lambe T, Linterman MA. A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice. Med (N Y) 2021;2:243-262.e8. [PMID: 33521747 DOI: 10.1016/j.medj.2020.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Qorib M, Oladunni T, Denis M, Ososanya E, Cotae P. Covid-19 Vaccine Hesitancy: Text Mining, Sentiment Analysis and Machine Learning on COVID-19 Vaccination Twitter Dataset. Expert Syst Appl 2022;:118715. [PMID: 36092862 DOI: 10.1016/j.eswa.2022.118715] [Reference Citation Analysis]
2 Palatella M, Guillaume SM, Linterman MA, Huehn J. The dark side of Tregs during aging. Front Immunol 2022;13:940705. [DOI: 10.3389/fimmu.2022.940705] [Reference Citation Analysis]
3 Fernández-Lázaro D, Garrosa M, Sánchez-Serrano N, Garrosa E, Jiménez-Callejo E, Pardo Yanguas MD, Mielgo-Ayuso J, Seco-Calvo J. Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study. Vaccines (Basel) 2022;10:1170. [PMID: 35893819 DOI: 10.3390/vaccines10081170] [Reference Citation Analysis]
4 Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, Hooda D, Khan R, Arora S, Singh A, Chirico F, Sharma M. Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India. Vaccines 2022;10:1048. [DOI: 10.3390/vaccines10071048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Minaya C, McKay D, Benton H, Blanc J, Seixas AA. Medical Mistrust, COVID-19 Stress, and Intent to Vaccinate in Racial-Ethnic Minorities. Behav Sci (Basel) 2022;12:186. [PMID: 35735396 DOI: 10.3390/bs12060186] [Reference Citation Analysis]
6 Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022;14:1066. [DOI: 10.3390/pharmaceutics14051066] [Reference Citation Analysis]
7 Stebbings R, Jones C, Cotton P, Armour G, Maguire S, Skellett V, Tang CM, Goodman J, Brady T, Takahashi V, Daunt A, Lapointe JM, Cohen TS. SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19). Front Immunol 2022;13:836492. [PMID: 35493482 DOI: 10.3389/fimmu.2022.836492] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maciorowski D, Diop C, Bhatt U, Estelien R, Li D, Chauhan R, Vandenberghe LH, Zabaleta N. Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging. Viruses 2022;14:820. [PMID: 35458550 DOI: 10.3390/v14040820] [Reference Citation Analysis]
9 Attia S, Mausbach K, Klugar M, Howaldt H, Riad A. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees. Front Public Health 2022;10:846861. [DOI: 10.3389/fpubh.2022.846861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Chukwu CA, Mahmood K, Elmakki S, Gorton J, Kalra PA, Poulikakos D, Middleton R. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre. PLoS One 2022;17:e0265130. [PMID: 35271655 DOI: 10.1371/journal.pone.0265130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Savina K, Sreekumar R, Soonu VK, Variyar EJ. Various vaccine platforms in the field of COVID-19. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00215-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 50.0] [Reference Citation Analysis]
13 Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study. Vaccines (Basel) 2021;9:1437. [PMID: 34960183 DOI: 10.3390/vaccines9121437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
14 Weinberger B. Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population. Vaccines (Basel) 2021;9:1435. [PMID: 34960181 DOI: 10.3390/vaccines9121435] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study. Vaccines (Basel) 2021;9:1424. [PMID: 34960170 DOI: 10.3390/vaccines9121424] [Cited by in F6Publishing: 34] [Reference Citation Analysis]
16 Lee JL, Linterman MA. Mechanisms underpinning poor antibody responses to vaccines in ageing. Immunol Lett 2021;241:1-14. [PMID: 34767859 DOI: 10.1016/j.imlet.2021.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
17 Hill DL, Whyte CE, Innocentin S, Lee JL, Dooley J, Wang J, James EA, Lee JC, Kwok WW, Zand MS, Liston A, Carr EJ, Linterman MA. Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans. Elife 2021;10:e70554. [PMID: 34726156 DOI: 10.7554/eLife.70554] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
18 Canti L, Humblet-Baron S, Desombere I, Neumann J, Pannus P, Heyndrickx L, Henry A, Servais S, Willems E, Ehx G, Goriely S, Seidel L, Michiels J, Willems B, Liston A, Ariën KK, Beguin Y, Goossens ME, Marchant A, Baron F. Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. J Hematol Oncol 2021;14:174. [PMID: 34689821 DOI: 10.1186/s13045-021-01190-3] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
19 Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021;22:e13313. [PMID: 34269511 DOI: 10.1111/obr.13313] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
20 Eisenbarth SC, Baumjohann D, Craft J, Fazilleau N, Ma CS, Tangye SG, Vinuesa CG, Linterman MA. CD4+ T cells that help B cells - a proposal for uniform nomenclature. Trends Immunol 2021;42:658-69. [PMID: 34244056 DOI: 10.1016/j.it.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
21 Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A, Elmer A, Kingston N, Graves B, Le Gresley E, Caputo D, Bergamaschi L, Smith KGC, Bradley JR, Ceron-Gutierrez L, Cortes-Acevedo P, Barcenas-Morales G, Linterman MA, McCoy LE, Davis C, Thomson E, Lyons PA, McKinney E, Doffinger R, Wills M, Gupta RK; CITIID-NIHR BioResource COVID-19 Collaboration. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 2021;596:417-22. [PMID: 34192737 DOI: 10.1038/s41586-021-03739-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 170] [Article Influence: 18.0] [Reference Citation Analysis]
22 Fra-Bido S, Walker SA, Innocentin S, Linterman MA. Optimized immunofluorescence staining protocol for imaging germinal centers in secondary lymphoid tissues of vaccinated mice. STAR Protoc 2021;2:100499. [PMID: 34195671 DOI: 10.1016/j.xpro.2021.100499] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Spencer AJ, McKay PF, Belij-Rammerstorfer S, Ulaszewska M, Bissett CD, Hu K, Samnuan K, Blakney AK, Wright D, Sharpe HR, Gilbride C, Truby A, Allen ER, Gilbert SC, Shattock RJ, Lambe T. Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice. Nat Commun 2021;12:2893. [PMID: 34001897 DOI: 10.1038/s41467-021-23173-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
24 Lee CY, Lowen AC. Animal models for SARS-CoV-2. Curr Opin Virol 2021;48:73-81. [PMID: 33906125 DOI: 10.1016/j.coviro.2021.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
25 Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y. Precision therapeutic targets for COVID-19. Virol J 2021;18:66. [PMID: 33781287 DOI: 10.1186/s12985-021-01526-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
26 [DOI: 10.1101/2021.01.28.428665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]